日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Special consideration: commentary on the 2025 FDA Bioanalytical Method Validation for Biomarkers

特别关注:对 2025 年 FDA 生物标志物生物分析方法验证的评论

Quadrini, Karen J; Aubrecht, Jiri; King, Nicholas M P; Fernandez-Metzler, Carmen; Ni, Yan G; Sauer, John-Michael; Stevenson, Lauren; Piccoli, Steven P

Validation of high-sensitivity assays to quantitate cerebrospinal fluid and serum β-galactosidase activity in patients with GM1-gangliosidosis.

验证高灵敏度检测方法在GM1神经节苷脂病患者脑脊液和血清β-半乳糖苷酶活性定量中的应用

Quadrini Karen J, Vrentas Catherine, Duke Christian, Wilson Chris, Hinderer Christian J, Weinstein David A, Al-Zaidy Samiah A, Browne Susan E, Wilson James M, Ni Yan G

FoxO, autophagy, and cardiac remodeling

FoxO、自噬和心脏重塑

Ferdous, Anwarul; Battiprolu, Pavan K; Ni, Yan G; Rothermel, Beverly A; Hill, Joseph A

Foxo transcription factors blunt cardiac hypertrophy by inhibiting calcineurin signaling

Foxo转录因子通过抑制钙调磷酸酶信号传导来减弱心脏肥大。

Ni, Yan G; Berenji, Kambeez; Wang, Na; Oh, Misook; Sachan, Nita; Dey, Asim; Cheng, Jun; Lu, Guangrong; Morris, David J; Castrillon, Diego H; Gerard, Robert D; Rothermel, Beverly A; Hill, Joseph A